Abbott Laboratories and Roche Among Key Players in Zika Testing Market

Comments · 22 Views

The global Zika Testing Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.9% and reach a size of USD 328.3 million by 2028, up from USD 179.2 million in 2020.

The global Zika Testing Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 7.9% and reach a size of USD 328.3 million by 2028, up from USD 179.2 million in 2020. The market growth is being driven by the rising prevalence of the Zika virus, increasing public awareness, and the growing footprint of local manufacturers of rapid tests for Zika virus. The market has also been impacted by the adoption of technologically advanced tests across several countries.

Zika virus is a member of the Flaviviridae family and is transmitted by daytime active Aedes mosquitoes. It can cause various infections, including fever, Japanese encephalitis, yellow fever, and dengue. Common symptoms of the Zika virus infection include joint and muscle pain, rash, conjunctivitis, fever, and headache. The virus can be transmitted from one person to another through sexual contact or from an infected mother to her fetus. Pregnant women infected with Zika virus have a high risk of miscarriage, preterm birth, or serious birth defects, including microcephaly or other congenital brain abnormalities. Therefore, the demand for Zika virus testing among pregnant women is increasing.

To request sample report visit @

The global market growth is also driven by increasing investments by market players in research and development activities to develop innovative and advanced tests, and growing public awareness about Zika virus infection, transmission, and the benefits of early detection.

However, the slow implementation of advanced technologies in developing countries and the high cost of branded test kits are expected to hinder the growth of the Zika virus market to some extent. Additionally, the IgM test is known to cause several side effects such as multiple punctures for locating patient's vein, fainting, or hematoma, which is another crucial factor that may hamper global market growth.

To know latest report insights visit @

Based on the type of testing, the serological testing segment accounted for the largest share in 2020 and is expected to account for a significant revenue share over the forecast period. Among the end-use segments, the research institutes segment is projected to account for significant revenue growth between 2021 and 2028. Research institutes such as the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institutes of Health (NIH) are collaborating with various organizations, pharmaceutical biotechnology companies to understand the virus better and to develop advanced testing kits. Moreover, increasing funds for research and development activities are further fueling segment growth.

The Asia Pacific market is projected to account for the fastest revenue growth during the forecast period. The region's growth is fueled by increasing awareness about the Zika virus and the benefits of early detection, growing research on infection, initiatives from governments to improve the healthcare system, and increasing investments in RD activities.

To request report customization visit @

The market in Latin America is expected to account for a considerably high revenue growth throughout the forecast period, owing to factors such as rising prevalence of Zika virus infection, growing government initiatives to create awareness about the disease, and increasing research on developing advanced tests.

Key players operating in the global Zika Testing Market include Abbott Laboratories, Altona Diagnostics GmbH, Chembio Diagnostic Systems Inc., ELITechGroup, F. Hoffmann-La Roche Ltd, Genekam, Luminex Corporation, Novacyt Group, Quest Diagnostics, and Siemens AG.

The global Zika Testing Market has been segmented based on Diagnostic Test Type, End-Use, and Region. The diagnostic test type segment includes molecular testing and serological testing. The end-use segment includes diagnostic laboratories, hospitals and clinics, and research institutes. The regional segment includes North America, Europe, Asia Pacific, Latin America, and the Middle East Africa.

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.

Contact Us:

John W
Head of Business Development
Reports And Data | Web:
Direct Line: +1-212-710-1370
LinkedIn | Twitter | Blogs

Read the innovative blog at